Brett Stevens
Overview
Explore the profile of Brett Stevens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minhajuddin M, Winters A, Ye H, Pei S, Stevens B, Gillen A, et al.
Haematologica
. 2024 Jun;
110(1):103-116.
PMID: 38934082
The treatment of blast phase chronic myeloid leukemia (bpCML) remains a challenge due, at least in part, to drug resistance of leukemia stem cells (LSC). Recent clinical evidence suggests that...
2.
Intermittent Search, Not Strict Lévy Flight, Evolves under Relaxed Foraging Distribution Constraints
Campeau W, Simons A, Stevens B
Am Nat
. 2024 Mar;
203(4):513-527.
PMID: 38489781
AbstractThe survival of an animal depends on its success as a forager, and understanding the adaptations that result in successful foraging strategies is an enduring endeavour of behavioral ecology. Random...
3.
Croucher C, Powell W, Stevens B, Miller-Dicks M, Powell V, Wiltshire T, et al.
IEEE Trans Vis Comput Graph
. 2023 Sep;
30(8):5765-5781.
PMID: 37695974
Virtual reality (VR) research has provided overviews of locomotion techniques, how they work, their strengths and overall user experience. Considerable research has investigated new methodologies, particularly machine learning to develop...
4.
Gutman J, Winters A, Kent A, Amaya M, McMahon C, Smith C, et al.
Haematologica
. 2023 Apr;
108(10):2616-2625.
PMID: 37051756
Venetoclax+azacitidine is the standard of care for newly-diagnosed patients with acute myeloid leukemia (AML) for whom intensive chemotherapy is inappropriate. Efforts to optimize this regimen are necessary. We designed a...
5.
Stevens B, Pollyea D
Haematologica
. 2023 Feb;
108(7):1715-1717.
PMID: 36794503
No abstract available.
6.
Islam N, Reuben J, Dale J, Gutman J, McMahon C, Amaya M, et al.
JCO Clin Cancer Inform
. 2022 Oct;
6:e2200030.
PMID: 36194842
Purpose: There are currently limited objective criteria to help assist physicians in determining whether an individual patient with acute myeloid leukemia (AML) is likely to do better with induction with...
7.
Campeau W, Simons A, Stevens B
PLoS Comput Biol
. 2022 Jan;
18(1):e1009490.
PMID: 35041659
Lévy flight is a type of random walk that characterizes the behaviour of many natural phenomena studied across a multiplicity of academic disciplines; within biology specifically, the behaviour of fish,...
8.
Brown P, Powell W, Dansey N, Al-Abbadey M, Stevens B, Powell V
Cyberpsychol Behav Soc Netw
. 2021 Oct;
25(1):66-71.
PMID: 34652215
Virtual reality (VR) has shown promising results as an adjunct therapy for pain management. Recent literature exploring the use of VR for pain management among a chronic pain (CP) population...
9.
Cherry E, Abbott D, Amaya M, McMahon C, Schwartz M, Rosser J, et al.
Blood Adv
. 2021 Oct;
5(24):5565-5573.
PMID: 34610123
Venetoclax (ven) plus azacitidine (aza) is the standard of care for patients with newly diagnosed acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy (IC). Some patients who...
10.
Amaya M, Inguva A, Pei S, Jones C, Krug A, Ye H, et al.
Blood
. 2021 Sep;
139(4):584-596.
PMID: 34525179
Acute myeloid leukemia (AML) is characterized by the presence of leukemia stem cells (LSCs), and failure to fully eradicate this population contributes to disease persistence/relapse. Prior studies have characterized metabolic...